XML 143 R122.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SCHEDULE II - Condensed Financial Information of Registrant (Details 2) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Operating activities                      
Net income $ 20,471 $ (25,167) $ 20,307 $ 22,728 $ 11,632 $ 19,581 $ 16,984 $ 15,633 $ 38,339 $ 63,830 $ 43,566
Adjustments to reconcile net income to net cash (used in) provided by operating activities:                      
Provision for depreciation and amortization                 4,063 4,215 2,123
Share based compensation expense                 7,178 6,228 7,688
Net cash provided by operating activities                 1,489,022 290,028 207,816
Investing activities                      
Net cash used in investing activities                 (263,359) (266,772) (104,741)
Financing activities                      
Dividends paid                 (36,720) (36,123) (50,832)
Senior debt issuance                 60,000 20,000 10,000
Senior debt repayments                 (20,000) 0 0
Issuances of common shares under equity incentive plans                 8,286 5,172 1,708
Common share repurchases                 (2,899) (2,239) (9,448)
Net cash provided by (used in) financing activities                 7,956 (14,294) (49,364)
Cash and cash equivalents at beginning of year       172,457         172,457    
Cash and cash equivalents at end of year 206,912       172,457       206,912 172,457  
Supplemental information                      
Interest paid                 12,354 11,269 8,909
Parent Company                      
Operating activities                      
Net income                 38,339 63,830 43,566
Adjustments to reconcile net income to net cash (used in) provided by operating activities:                      
Provision for depreciation and amortization                 182 176 176
Share based compensation expense                 7,178 6,228 7,688
Equity in undistributed earnings of subsidiaries                 (49,592) 6,000 (23,662)
Changes in operating assets and liabilities:                 (2,782) (5,653) 684
Net cash provided by operating activities                 (6,675) 70,581 28,452
Investing activities                      
Dividends from subsidiaries                 0 0 20,000
Net cash used in investing activities                 0 0 20,000
Financing activities                      
Dividends paid                 (36,720) (36,123) (50,832)
Senior debt issuance                 60,000 20,000 10,000
Senior debt repayments                 (20,000) 0 0
Subsidiary note repayments                 0 (60,000) 0
Debt issue costs paid                 (711) 0 0
Issuances of common shares under equity incentive plans                 8,286 5,172 1,708
Common share repurchases                 (2,899) (2,239) (9,448)
Net cash provided by (used in) financing activities                 7,956 (73,190) (48,572)
Increase in cash and cash equivalents                 1,281 (2,609) (120)
Cash and cash equivalents at beginning of year       $ 240       $ 2,849 240 2,849 2,969
Cash and cash equivalents at end of year $ 1,521       $ 240       1,521 240 2,849
Supplemental information                      
Interest paid                 $ 5,710 $ 5,052 $ 4,612